BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 7224878)

  • 21. [Invasive properties of follicular adenoma and follicular carcinoma of the thyroid gland].
    Rudkovskiĭ MS; Gurevich GI
    Vestn Khir Im I I Grek; 1988 Jul; 141(7):67-8. PubMed ID: 3222901
    [No Abstract]   [Full Text] [Related]  

  • 22. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms.
    Mehrotra P; Okpokam A; Bouhaidar R; Johnson SJ; Wilson JA; Davies BR; Lennard TW
    Histopathology; 2004 Nov; 45(5):493-500. PubMed ID: 15500653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular and capsular pseudoinvasion in thyroid neoplasms.
    Chebib I; Opher E; Richardson ME
    Int J Surg Pathol; 2009 Dec; 17(6):449-51. PubMed ID: 19666948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
    Furlan JC; Bedard YC; Rosen IB
    J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Renal metastasis of a metastasizing thyroid adenoma].
    Ramthor W; Müller GW
    Z Urol Nephrol; 1980 Jun; 73(6):427-32. PubMed ID: 7191605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Poorly-differentiated thyroid carcinoma: morphological verification and differential diagnosis].
    Friedman MV
    Vopr Onkol; 2006; 52(1):47-53. PubMed ID: 16715703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
    Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM
    Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Differentiated thyroid carcinoma: prognostic factors].
    Györy F; Lukács G; Nagy EV; Juhász F; Mezösi E; Szakáll S; Máth J; Balázs G
    Magy Seb; 2001 Apr; 54(2):69-74. PubMed ID: 11339092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computerized nuclear morphometry in thyroid follicular neoplasms.
    Wang SL; Wu MT; Yang SF; Chan HM; Chai CY
    Pathol Int; 2005 Nov; 55(11):703-6. PubMed ID: 16271082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The differential diagnosis of follicular adenomas and carcinomas in fine needle biopsies of the thyroid gland by means of automatic image analysis (author's transl)].
    Schuh D; Steidl R; Voss K
    Zentralbl Allg Pathol; 1980; 124(6):557-60. PubMed ID: 7210935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The value of frozen section in intraoperative surgical management of thyroid follicular carcinoma.
    Dosen D; Turić M; Smalcelj J; Janusić R; Grgić MP; Separović V
    Head Neck; 2003 Jul; 25(7):521-8. PubMed ID: 12808654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Follicular and Hurthle cell tumors of the thyroid gland. Possibilities of preoperative differential diagnosis].
    Grineva EN; Goriushkina EV; Malakhova TV; Tsoĭ UA
    Vopr Onkol; 2004; 50(1):41-5. PubMed ID: 15088519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
    Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
    Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
    Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
    Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Galectin-3 is a presurgical marker of human thyroid carcinoma.
    Orlandi F; Saggiorato E; Pivano G; Puligheddu B; Termine A; Cappia S; De Giuli P; Angeli A
    Cancer Res; 1998 Jul; 58(14):3015-20. PubMed ID: 9679965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical implications of the rare thyroid carcinoma which is indistinguishable from a follicular adenoma.
    Blum M; Feiner HD; Worth MH; King LW
    Am J Med Sci; 1978; 276(1):99-104. PubMed ID: 727220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cytomorphological and cytochemical studies of experimentally-induced thyroid tumors in the rat].
    Müller P; Hambsch K; Haupt R; Herrmann F; Sorger D
    Zentralbl Pathol; 1991; 137(1):29-34. PubMed ID: 2059608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunostaining of galectin-3 and CD44v6 using fine-needle aspiration for distinguishing follicular carcinoma from adenoma.
    Maruta J; Hashimoto H; Yamashita H; Yamashita H; Noguchi S
    Diagn Cytopathol; 2004 Dec; 31(6):392-6. PubMed ID: 15540177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
    Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
    Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [On problems of the term "atypical adenoma" of the thyroid gland (author's transl)].
    Kühne W; Willgeroth C
    Zentralbl Allg Pathol; 1982; 126(1-2):142-50. PubMed ID: 7090593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.